Osteopathic Visceral Manipulation on Functional Constipation in Obese Adults
1 other identifier
interventional
110
1 country
1
Brief Summary
Functional constipation in obese adults is a prevalent gastrointestinal issue characterized by infrequent bowel movements, difficulty during defecation, or a sensation of incomplete evacuation. Obesity is a significant risk factor for functional constipation due to several physiological and lifestyle-related factors. Excess body weight, particularly in the abdominal region, may exert pressure on the colon, leading to disrupted bowel function. Additionally, dietary habits common among obese individuals, such as low fiber intake and inadequate hydration, can worsen constipation. Sedentary lifestyles further contribute to reduced gastrointestinal motility. Addressing functional constipation in obese adults requires a multifaceted approach, including dietary modifications to increase fiber and fluid intake, regular physical activity, and, in some cases, medical interventions to alleviate symptoms and improve quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 25, 2025
CompletedFirst Submitted
Initial submission to the registry
April 7, 2025
CompletedFirst Posted
Study publicly available on registry
April 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2025
CompletedApril 29, 2025
April 1, 2025
1 month
April 7, 2025
April 25, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Stool consistency
Patients were asked to describe the consistency of their stools during the previous month, choosing between the terms "hard or very hard," "not too hard, not too soft (normal)," "soft or very soft," "mucous, with undigested food," and "liquid," they also had the opportunity to answer that the stools were "variable" in consistency. In addition, patients were asked to choose the BSS stool type that best represented their stools on a picture chart
at baseline and at three weeks
Defecation Pain
Clearly explain to the patient the purpose of assessing their defecation pain using Arabic version of Visual Analogue Scale (VAS) form: A horizontal or vertical line, typically 10 centimeters in length, anchored by two descriptors at each end representing "no pain" and "worst possible pain."
at baseline and at three weeks
Secondary Outcomes (2)
Defecation frequency
at baseline and at three weeks
Dose of oral laxative
at baseline and at three weeks
Study Arms (2)
osteopathic visceral manipulation
EXPERIMENTALGroup A received osteopathic visceral manipulation with standard care
control
NO INTERVENTIONGroup B received standard care only
Interventions
The procedure begins with the patient lying in a comfortable supine position to ensure relaxation and access to the abdominal region. Gentle palpation is used to assess tissue mobility and identify any restrictions or tension points. The practitioner applies light, rhythmic pressure to the gastroduodenal junction to stimulate movement and improve coordination between the stomach and duodenum. Attention is then given to the sphincter of Oddi, where soft, sustained pressure is employed to facilitate the release of bile and pancreatic juices, aiding digestive processes. Moving to the duodenojejunal flexure, the therapist uses gentle stretching and mobilization techniques to alleviate any obstructions, promoting smoother passage of intestinal contents. Finally, the sigmoid colon is manipulated with circular and oscillatory pressures to enhance peristalsis and relieve constipation.
Eligibility Criteria
You may qualify if:
- patients diagnosed with functional constipation according to Rome IV criteria
- Body mass index (BMI) ≥ 30 kg/m²
- Ability to provide informed consent
You may not qualify if:
- patients with organic gastrointestinal diseases, Pregnancy or lactation
- Participation in another clinical trial within the last 30 days, Endocrine and metabolic disorders (eg, hypothyroidism, hypercalcemia, diabetes mellitus, diabetes insipidus)
- Neurologic and psychiatric disorders (spina bifida, cerebral palsy, anorexia nervosa, known autism spectrum disorders)
- Secondary constipation to drug consumption, History of abdominal surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MTI Universitylead
Study Sites (1)
faculty of physical therapy ,Cairo University
Cairo, 4450113, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assisstant professor
Study Record Dates
First Submitted
April 7, 2025
First Posted
April 13, 2025
Study Start
March 25, 2025
Primary Completion
April 25, 2025
Study Completion
April 25, 2025
Last Updated
April 29, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share